4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-034625
Options or other derivatives
- Chief Operating Officer acquired 376,629 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hensley Mark Earl · Chief Operating Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-30 | Grant or award : show line 1 in the form Restricted Stock Units | +188,315 | 188,315 | D |
| 2026-01-30 | Grant or award : show line 2 in the form Performance Stock Units | +188,314 | 188,314 | D |
Loading xslF345X05/ownership.xml…